Comcast Corporation (NASDAQ:CMCSA) has been given an “A-” credit rating by analysts at Morningstar. The firm’s “A-” rating indicates that the company is a low default risk. They also gave their stock a two star rating. On Friday shares of Comcast Corporation (NASDAQ:CMCSA) closed at $60.37. Company’s sales growth for last 5 years was 14.00% and EPS growth for next 5 years is recorded as 17.00%.
On March 4, Tower Semiconductor Ltd. (NASDAQ:TSEM) announced that it has begun the mass production of an IR sensor to be used by the chip-making giant Intel in their 3D sensor solutions. Intel has chosen Tower Semiconductor’s CMOS image sensor platform that has a number of advanced features that are appealing to a company like Intel. Tower Semiconductor Ltd. (NASDAQ:TSEM) in last trading activity decreased -1.71% to close at $17.50. Company weekly performance is 8.76% while its quarterly performance stands at 31.48%. Tower Semiconductor Ltd. (NASDAQ:TSEM) is -3.85% away from its 52 week high.
On March 3, it was reported that, Chicago-based Essex Property Trust, Inc. (NYSE:ESS) has acquired the 8th+Hope luxury apartment high-rise at 801 S. Hope St. in downtown Los Angeles from developer Wood Partners for $200 million, or about $690,000 per unit. On last trading day Essex Property Trust Inc. (NYSE:ESS) decreased -3.02% to close at $219.36. Its volatility for the week is 1.83% while volatility for the month is 1.90%. ESS’s sales growth for past 5 years was 19.00% and its EPS growth for past 5 years was -3.10%. Essex Property Trust Inc. (NYSE:ESS) monthly performance is -3.86%.
The US Food and Drug Administration (FDA) has approved Bristol-Myers Squibb Company (NYSE:BMY)’s Opdivo (nivolumab) injection, for intravenous use, for the treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity decreased -1.41% to close at $65.12. Company weekly performance is 6.89% while its quarterly performance stands at 11.01%. Bristol-Myers Squibb Company (NYSE:BMY) is -3.07% away from its 52 week high.
On March 2, Signal Genetics, Inc. (NASDAQ:SGNL) announced that the underwriters of its recent public offering have exercised their option to purchase an additional 482,142 shares of its common stock at a price of $2.80 per share. On last trading day Signal Genetics, Inc. (NASDAQ:SGNL) decreased -3.91% to close at $2.70. Its volatility for the week is 9.48% while volatility for the month is 23.21%. Signal Genetics, Inc. (NASDAQ:SGNL) monthly performance is 41.36%.